The Medical Summarization Debate: To Build or To Buy

How to evaluate building on top of an LLM vs. buying a solution

EvolutionIQ
November 20, 2025

A 2025 report published by MIT, reports that purchasing AI tools from specialized vendors and building partnerships succeed about 67% of the time, while internal builds succeed only one-third as often purchased solutions delivered more reliable results.

This whitepaper outlines a decision framework to help technology and business leaders assess their options confidently. It highlights how to balance control with agility and design an implementation approach that positions your organization to fully leverage Medical Summarization as a strategic capability.


Related posts

Charles Zhu
Agentic AI Unpacked: Strategy and Challenges in Bodily Injury Claims
Blogs
All
EvolutionIQ
Overcoming the Comorbidity Tax
Blogs
All
John Ross
From Christmas Lights to Green Lights: Moving an AI Pilot to Enterprise Adoption
Blogs
All